1-7 of 7
Jose-Angel Hernandez, MD
Close
Sort by
Journal Articles

Clinical and Biological Impact of TP53 Alterations in Del(11q) Chronic Lymphocytic Leukemia

Claudia Pérez Carretero, MSc, BSc, Miguel Quijada Álamo, MSc, Maria Hernandez-Sanchez, PhD, Ana E. Rodriguez, PhD, Ana B Herrero, PhD, Jesus M Hernández-Sánchez, PhD, Marta Martín Izquierdo, MSc, Teresa González, PhD, Sandra Santos-Mínguez, Cristina Miguel-García, Araceli Rubio-Martínez, Alfonso García de Coca, MD PhD, Julio Dávila, Jose-Angel Hernandez, MD PhD, Rocio Benito, PhD, José Luis Ordóñez, PhD, Jesus Maria Hernández-Rivas, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-141015
Published: 2020
Journal Articles

Biological Impact of Monoallelic and Biallelic BIRC3 Loss in Del(11q) Chronic Lymphocytic Leukemia Progression

Miguel Quijada Álamo, MSc, Maria Hernandez-Sanchez, PhD, Ana E. Rodriguez, PhD, Claudia Pérez Carretero, MSc, BSc, Marta Martín Izquierdo, MSc, Verónica Alonso Pérez, PhD, Ignacio García-Tuñón, PhD, Jose Maria Bastida, MDPhD, Maria Jesus Vidal, MD, Josefina Galende DEL Canto, MD, Carlos Aguilar, MD, José Antonio Queizán, MD, Isabel González-Gascón Y Marín, MD PhD, Jose-Angel Hernandez, MD PhD, Rocio Benito, PhD, José Luis Ordóñez, PhD, Jesus Maria Hernández-Rivas, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4.
https://doi.org/10.1182/blood-2020-142658
Published: 2020
Journal Articles

Idelalisib for Relapsed/Refractory Follicular Lymphoma: Retrospective Study from Spanish Lymphoma Group Geltamo (GELT-IDE-2018-02)

Juan-Manuel Sancho, MD PhD, Olga García, Pablo Mozas, Santiago Mercadal, MD, Eva Donato, MD, Ana Muntañola Prat, MD, Javier Lopez Jimenez, MD, Pascual Fernandez Abellan, PhD, Jose-Angel Hernandez, MD, Maria J. Rodriguez-Salazar, MD, Samuel Romero, MD, Ana Marin Niebla, PhD, Angel Ramirez Payer, Raul Cordoba, MD PhD, Jose Luis Bello, MD, Beatriz Cuevas, MD, Itziar Oiartzabal, MD, Alejandro Martín, MD PhD, Jose Javier Sanchez Blanco, Nicholas Kelleher, MD, Ana Lafuente, MD, Marc Sorigué, MD, López Guillermo Armando, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5249.
https://doi.org/10.1182/blood-2019-125921
Published: 2019
Journal Articles

Comparison of Clinical Characteristics and Prognosis of a Series of Patients from the Spanish Registry of MDS Diagnosed with Myelodysplastic/Myeloproliferative Neoplasms According to the 2016 Reviewed Classification of the World Health Organization

Blanca Xicoy, María-José Jimenez, Olga García, Marisa Calabuig, MD, Rosa Coll, MD, Elisa Orna, María Teresa Cedena, Ana Vicente, Eugenia Rivero, Itziar Oiartzabal Ormategui, Lurdes Zamora, PhD, Jose-Angel Hernandez, MD, Natalia Estrada, Marta Callejas, PhD, Bernardo Javier González González, Raquel de Paz, Montserrat Cortes, Laura Palomo, MSc, Joan Bargay, MD PhD, María-Lavinia Villalobos, Alicia Bailen, María-Ángeles Montañés, Teresa Bernal Del Castillo, MD PhD, Félix López Cadenas, MD, Javier Grau, Salut Brunet, MD PhD, Ana Jiménez, Guillermo Sanz, Josefa Marco, Tzu Hua Chen-Liang
Journal: Blood
Blood (2018) 132 (Supplement 1): 3048.
https://doi.org/10.1182/blood-2018-99-111883
Published: 2018
Journal Articles

Phase 2 Randomized Trial Comparing Standard RCHOP Versus Brcap (bortezomib, rituximab, cyclophosphamide, adriamycin and prednisone) As First Line Treatment in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma (DLBCL). a Study from Spanish Group Geltamo

Eva González-Barca, MD PhD, Estrella Carrillo-Cruz, MD, Carlos Grande, MD PhD, Alejandro Martín, MD PhD, Mónica Coronado, MD, Santiago Montes-Moreno, MD, Santiago Mercadal, MD, Josep Maria Roncero, MD, Jaime Pérez de Oteyza, MD, Concepción Nicolás, MD, María José Rodríguez-Salazar, MD, Juan-Manuel Sancho, Luis Palomera, MD PhD, Javier López-Jiménez, MD, Carmen Albo, MD, Francisco-Javier Peñalver, MD, José Ángel Hernández, MD, Armando López-Guillermo, MD PhD, María José Ramírez, MD, Isidro Jarque, MD, Joan Bargay, MD, Miguel Canales, MD PhD, Eulogio Conde, MD PhD, Dolores Caballero, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4201.
https://doi.org/10.1182/blood.V128.22.4201.4201
Published: 2016
Journal Articles

Incidence, Treatment and Prognosis of Patients with Relapsed Burkitt Lymphoma/Leukemia Treated with Specific Chemotherapy or Immunochemotherapy in Spain

Alberto Pineda, MD, Juan-Manuel Sancho, MD PhD, Olga Garcia, MD, Jordi Esteve, MD PhD, Mar Tormo, MD PhD, Pilar Martinez, MD, Ferran Vall-llovera, MD, Rodrigo Martino, MD PhD, Pau Montesinos, MD, Jose Gonzalez-Campos, MD, Juan Bergua, María Calbacho, MD, Cristina Gil, MD, Ana Vicent, MD, Antònia Cladera, MD, Jesus Hernandez, MD, Maria-José Moreno, MD, Alfons Serrano, MD, Natalia Alonso, MD, Raimundo García, MD, Pere Barba, MD PhD, Angeles Fernandez, MD, Pilar Miralles, MD PhD, Andrés Novo, MD, Jose Maria Moraleda, MDPhD, José Ángel Hernández, MD, Eugenia Abella, MD PhD, Magdalena Sanchez, MD, Maria-Elsa Lopez, MD, Teresa Bernal, MD, Mª Carmen Mateos, MD, Esperanza Lavilla, MD, Josep-Maria Ribera, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2723.
https://doi.org/10.1182/blood.V126.23.2723.2723
Published: 2015
Journal Articles

Phase 2 Randomized Trial Comparing 6 Cycles of Standard RCHOP Chemotherapy Vs 6 Cycles of Brcap (bortezomib, rituximab, cyclophosphamide, adriamicine and prednisone) As First Line Treatment in Young Patients with Poor Prognosis Diffuse Large B-Cell Lymphoma (DLBCL): Interim Analysis

Eva González-Barca, MD PhD, Estrella Carrillo, Carlos Grande, MD, Alejandro Martín, Mónica Coronado, Santiago Montes-Moreno, Jaime Perez de Oteyza, Concepción Nicolas, Juan-Manuel Sancho, Luis Palomera, MDPhD, Javier Lopez, Sr., MD PhD, Armando Lopez-Guillermo, Francisco Javier Peñalver, José Ángel Hernández, MD, Maria Jose Ramirez, Isidro Jarque, Joan Bargay, MD, Mª José Rodríguez, Miguel Canales, Carmen Albo, Maite Encuentra, Dolores Caballero
Journal: Blood
Blood (2015) 126 (23): 1514.
https://doi.org/10.1182/blood.V126.23.1514.1514
Published: 2015